An N, S-acetylated L-cysteine-cysteamine conjugate hinders pyocyanin redox cycling to weaken Pseudomonas aeruginosa biofilm and dampens LPS-driven acute pulmonary inflammation
Michela BruschiiD, Sofia MasiniiD, Francesco Palma, Y Xiaoqiu, Cássia Lisboa BragaiD, Matteo Gregori, C Bucci, Francesca BartocciniiD, Michele MenottaiD, Elisabetta ManualiiD, Lucia MinelliiD, Daniela LigiiD, Ferdinando MannelloiD, Francesca MonittolaiD, Carolina Zara, Caterina Di PietroiD, Rita CrinelliiD, Giorgio BrandiiD, Giovanni PiersantiiD, Emanuela M. BrusciaiD, Giuditta Fiorella SchiavanoiD, Alessandra FraternaleiD
Abstract
The persistence of P. aeruginosa infections is largely driven by the secretion of several factors during invasion, including the redox-active phenazine pyocyanin (PYO), which promotes biofilm formation and oxidative stress. Biofilms contribute to chronic infections and antibiotic resistance, limiting the efficacy of conventional therapies. We found that a synthetic compound, I-152, a conjugate of N-acetyl-L-cysteine (NAC) and S-acetylcysteamine (also known as S-acetyl-{beta}-mercaptoethylamine; SMEA), effectively restored colistin susceptibility against P. aeruginosa by altering biofilm nanomechanical properties. These perturbations in matrix integrity were associated with I-152s ability to hinder the phenazine redox cycle, shifting PYO to a reduced state as well as enabling S-conjugate formation. The compound decreased PYO accumulation in bacterial cultures and PYO-generated reactive oxygen species (ROS) in macrophage cells. Together with PYO, LPS is another driver of ROS-dependent inflammatory signaling in the host, which leads to an uncontrolled cytokine response and organ damage, especially in patients with cystic fibrosis. I-152 treatment downregulated the expression of LPS-induced inflammatory cytokines, i.e., IL-6 and TNF-, in bone marrow-derived macrophages (BMDM) isolated from transgenic CFTR-/- and CFTR+/+ mice. Consistently, I-152 partially counteracted the inflammatory response in the P. aeruginosa LPS-induced acute lung injury murine model. Taken together, these results support I-152 as an adjunctive treatment for P. aeruginosa respiratory infections through a dual mechanism: combating antimicrobial resistance in biofilms and dampening host inflammation in the respiratory system. HighlightsO_LII-152 potentiates colistin activity against P. aeruginosa by compromising the biofilm surface C_LIO_LII-152 rewires the pyocyanin (PYO) redox state and forms covalent adducts with it C_LIO_LIPYO accumulation and PYO-induced ROS generation in macrophages is impaired by I-152 C_LIO_LIEx vivo, I-152 dampens excessive pro-inflammatory response to P. aeruginosa LPS in CFTR-/- and CFTR+/+ BM-derived macrophages C_LIO_LII-152 (140 mg/Kg) attenuates LPS-driven inflammation and lung damage in CFTR+/+ mice C_LI
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- Organism
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Electrochemical disruption of extracellular electron transfer inhibits Pseudomonas aeruginosa cell survival within biofilms and is synergistic with antibiotic treatment
F. Jimenez Otero, D. K. Newman, L. M. Tender·bioRxiv·Sep 15, 2022
- Biofilm-deficient mutants of Pseudomonas aeruginosa have wild-type levels of antibiotic tolerance in a model of cystic fibrosis lung infection
Jenny L. Littler, Niamh E. Harrington, … Freya Harrison·bioRxiv·Jul 16, 2026
- Universal antibiotic tolerance arising from antibiotic-triggered accumulation of redox metabolites
Kui Zhu, Shang Chen, … Lingchong You·bioRxiv·Oct 25, 2018
- Poly (acetyl arginyl) glucosamine attenuates Pseudomonas aeruginosa in a rat lung infection model
B. Garcia, M. S. McDaniel, … W. E. Swords·bioRxiv·Sep 15, 2021
- Pseudomonas aeruginosa co-opts host antibiotic metabolism by pyocyanin induction of cytochrome P450 enzymes
Emily G. Gracey, Sylvie E. Kandel, Jed Noah Lampe·bioRxiv·Jul 27, 2026
- Pseudomonas aeruginosa enhances the efficacy of norfloxacin against Staphylococcus aureus biofilms
G. Orazi, F. Jean-Pierre, G. O'Toole·bioRxiv·Mar 26, 2020